164 related articles for article (PubMed ID: 29459429)
1. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
2. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.
Esmaeli B; Nasser QJ; Cruz H; Fellman M; Warneke CL; Ivan D
Ophthalmology; 2012 May; 119(5):1078-82. PubMed ID: 22330966
[TBL] [Abstract][Full Text] [Related]
3. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
4. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS; Rubin ML; Xu S; Ning J; Tetzlaff M; Sagiv O; Kandl TJ; Esmaeli B
Br J Ophthalmol; 2019 Jul; 103(7):980-984. PubMed ID: 30131380
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
[TBL] [Abstract][Full Text] [Related]
8. Correlation of American Joint Committee on Cancer T category for eyelid carcinoma with outcomes in patients with periocular Merkel cell carcinoma.
Sniegowski MC; Warneke CL; Morrison WH; Nasser QJ; Frank SJ; Pfeiffer ML; El-Sawy T; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2014; 30(6):480-5. PubMed ID: 24841735
[TBL] [Abstract][Full Text] [Related]
9. Impact of AJCC 'T' designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid.
Nasser QJ; Roth KG; Warneke CL; Yin VT; El Sawy T; Esmaeli B
Br J Ophthalmol; 2014 Apr; 98(4):498-501. PubMed ID: 24429279
[TBL] [Abstract][Full Text] [Related]
10. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
13. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
14. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
15. Positive sentinel node in sebaceous carcinoma of the eyelid.
Savar A; Oellers P; Myers J; Prieto VG; Torres-Cabala C; Frank SJ; Ivan D; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2011; 27(1):e4-6. PubMed ID: 20940661
[TBL] [Abstract][Full Text] [Related]
16. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
Lee IJ; Koh JY
Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
[No Abstract] [Full Text] [Related]
17. Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual.
Ford J; Thakar S; Thuro B; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2017; 33(5):317-324. PubMed ID: 28350693
[TBL] [Abstract][Full Text] [Related]
18. Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K; Yasumatsu R; Toh S; Shiratsuchi H; Yoshida T; Nishiyama K; Yoshikawa H; Nakashima T; Nakagawa T
Auris Nasus Larynx; 2016 Dec; 43(6):666-71. PubMed ID: 26965587
[TBL] [Abstract][Full Text] [Related]
19. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience.
Ho M; Liu DT; Chong KK; Ng HK; Lam DS
Hong Kong Med J; 2013 Apr; 19(2):150-5. PubMed ID: 23535675
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management.
Tryggvason G; Bayon R; Pagedar NA
Head Neck; 2012 Dec; 34(12):1765-8. PubMed ID: 22267270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
